Group One Trading, L.P. Uro Gen Pharma Ltd. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Group One Trading, L.P. holds 7,774 shares of URGN stock, worth $89,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,774

Previous 9,289 16.31%

Holding current value

$89,012

Previous $155,000 36.77%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $19,240 - $27,148	-1,515 Reduced 16.31%	7,774 $98,000
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $118,156 - $178,348	9,289 New	9,289 $155,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $1,087 - $1,593	100 New	100 $1,000
Q1 2022 May 12, 2022	SELL	$5.92 - $9.73 $83,093 - $136,570	-14,036 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $267,215 - $566,094	-29,592 Reduced 67.83%	14,036 $133,000
Q3 2021 Nov 12, 2021	SELL	$14.31 - $18.39 $130,879 - $168,194	-9,146 Reduced 17.33%	43,628 $734,000
Q2 2021 Aug 10, 2021	SELL	$15.2 - $20.94 $544,540 - $750,175	-35,825 Reduced 40.43%	52,774 $806,000
Q1 2021 May 12, 2021	SELL	$17.99 - $26.96 $740,144 - $1.11 Million	-41,142 Reduced 31.71%	88,599 $1.73 Million
Q4 2020 Feb 10, 2021	SELL	$17.54 - $25.43 $441,464 - $640,047	-25,169 Reduced 16.25%	129,741 $2.34 Million
Q3 2020 Nov 12, 2020	BUY	$18.81 - $26.42 $1.69 Million - $2.38 Million	90,038 Added 138.79%	154,910 $2.99 Million
Q2 2020 Aug 13, 2020	BUY	$16.5 - $29.7 $708,345 - $1.28 Million	42,930 Added 195.65%	64,872 $1.69 Million
Q1 2020 May 13, 2020	SELL	$13.68 - $34.6 $84,186 - $212,928	-6,154 Reduced 21.9%	21,942 $391,000
Q4 2019 Feb 10, 2020	BUY	$21.11 - $34.86 $593,106 - $979,426	28,096 New	28,096 $938,000
Q4 2018 Feb 06, 2019	SELL	$38.35 - $50.39 $6,903 - $9,070	-180 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$41.65 - $51.7 $7,497 - $9,306	180 New	180 $9,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Uro Gen Pharma Ltd. Transaction History